Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Micronodular thymoma with lymphoid stroma diagnosed 10 years after the first operation: a case report.

Kaminuma Y, Tanahashi M, Yukiue H, Suzuki E, Yoshii N, Fujino T, Ogawa H, Niwa H.

J Med Case Rep. 2019 Mar 16;13(1):69. doi: 10.1186/s13256-019-2006-y.

2.

The juvenility-associated long noncoding RNA Gm14230 maintains cellular juvenescence.

Tano A, Kadota Y, Morimune T, Jam FA, Yukiue H, Bellier JP, Sokoda T, Maruo Y, Tooyama I, Mori M.

J Cell Sci. 2019 Apr 16;132(8). pii: jcs227801. doi: 10.1242/jcs.227801.

3.

A new approach to left sleeve pneumonectomy: complete VATS left pneumonectomy followed by right thoracotomy for carinal resection and reconstruction.

Fujino T, Tanahashi M, Yukiue H, Suzuki E, Yoshii N, Shitara M, Kaminuma Y, Niwa H.

Surg Case Rep. 2018 Aug 10;4(1):91. doi: 10.1186/s40792-018-0496-2.

4.

[Outcome of Surgical Treatment of Locally Advanced Lung Cancer after Induction Chemoradiotherapy].

Tanahashi M, Yukiue H, Suzuki E, Yoshii N, Kitazawa S, Kaminuma Y, Niwa H.

Kyobu Geka. 2018 Apr;71(4):278-283. Japanese.

PMID:
29755101
5.

Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratory function.

Ishihara T, Yamada K, Harada A, Yukiue H, Tanahashi M, Niwa H, Matsui T, Yokomura K, Ejima Y, Sasaki R.

Acta Oncol. 2018 Sep;57(9):1232-1239. doi: 10.1080/0284186X.2018.1468088. Epub 2018 May 3.

PMID:
29722594
6.
7.

[Surgical treatment for recurrent and second primary lung cancer].

Yukiue H, Tanahashi M, Haneda H, Suzuki E, Yoshii N, Niwa H.

Kyobu Geka. 2010 Oct;63(11):944-9. Japanese.

PMID:
20954348
8.

[Surgical treatment for Pancoast tumors--significance of surgical approach and induction chemoradiotherapy].

Yukiue H, Tanahashi M, Haneda H, Suzuki E, Yoshii N, Niwa H.

Kyobu Geka. 2010 Jan;63(1):4-8. Japanese.

PMID:
20077825
9.

Excision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancer.

Okuda K, Sasaki H, Hikosaka Y, Kawano O, Yukiue H, Yano M, Fujii Y.

J Surg Res. 2011 Jun 15;168(2):206-12. doi: 10.1016/j.jss.2009.09.006. Epub 2009 Sep 26.

PMID:
20070981
10.

CHRNA5 gene D398N polymorphism in Japanese lung adenocarcinoma.

Sasaki H, Hikosaka Y, Okuda K, Kawano O, Yukiue H, Yano M, Fujii Y.

J Surg Res. 2010 Jul;162(1):75-8. doi: 10.1016/j.jss.2009.01.008. Epub 2009 Feb 7.

PMID:
19577767
11.

Thymoma with dissemination: efficacy of macroscopic total resection of disseminated nodules.

Yano M, Sasaki H, Yukiue H, Kawano O, Okuda K, Hikosaka Y, Fujii Y.

World J Surg. 2009 Jul;33(7):1425-31. doi: 10.1007/s00268-009-0069-4.

PMID:
19424745
12.

[A case of non-small cell lung cancer with EGFR mutation responding to S-1 after a therapy with gefitinib].

Kawano O, Yano M, Sasaki H, Yukiue H, Okuda K, Fujii Y.

Gan To Kagaku Ryoho. 2009 Apr;36(4):675-7. Japanese.

PMID:
19381047
13.

MEK1 gene mutation in Japanese lung adenocarcinoma patients.

Sasaki H, Hikosaka Y, Okuda K, Kawano O, Yukiue H, Yano M, Fujii Y.

Mol Med Rep. 2009 Mar-Apr;2(2):153-5. doi: 10.3892/mmr_00000076.

PMID:
21475805
14.

Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.

Sasaki H, Shimizu S, Okuda K, Kawano O, Yukiue H, Yano M, Fujii Y.

Lung Cancer. 2009 Jun;64(3):295-300. doi: 10.1016/j.lungcan.2008.10.005. Epub 2008 Dec 5.

PMID:
19058870
15.

Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer.

Okuda K, Sasaki H, Yukiue H, Yano M, Fujii Y.

Cancer Sci. 2008 Nov;99(11):2280-5. doi: 10.1111/j.1349-7006.2008.00916.x.

16.

Fibroblast growth factor receptor 4 mutation and polymorphism in Japanese lung cancer.

Sasaki H, Okuda K, Kawano O, Yukiue H, Yano M, Fujii Y.

Oncol Rep. 2008 Nov;20(5):1125-30.

PMID:
18949411
17.

AKT1 and AKT2 mutations in lung cancer in a Japanese population.

Sasaki H, Okuda K, Kawano O, Yukiue H, Yano M, Fujii Y.

Mol Med Rep. 2008 Sep-Oct;1(5):663-6. doi: 10.3892/mmr_00000009.

PMID:
21479466
18.

EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.

Sasaki H, Okuda K, Shimizu S, Takada M, Kawahara M, Kitahara N, Okumura M, Matsumura A, Iuchi K, Kawaguchi T, Kubo A, Kawano O, Yukiue H, Yano M, Fujii Y.

J Cancer Res Clin Oncol. 2009 Feb;135(2):313-8. doi: 10.1007/s00432-008-0464-5. Epub 2008 Aug 23.

PMID:
18726117
19.

Thymic carcinoma with dissemination: a retrospective analysis of ten patients.

Yano M, Sasaki H, Yokoyama T, Yukiue H, Kawano O, Okuda K, Fujii Y.

Gen Thorac Cardiovasc Surg. 2008 Jul;56(7):335-9. doi: 10.1007/s11748-008-0227-x. Epub 2008 Jul 8.

PMID:
18607680
20.

EGFR polymorphism of the kinase domain in Japanese lung cancer.

Sasaki H, Endo K, Takada M, Kawahara M, Tanaka H, Kitahara N, Matsumura A, Iuchi K, Kawaguchi T, Okuda K, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y.

J Surg Res. 2008 Aug;148(2):260-3. doi: 10.1016/j.jss.2007.09.001. Epub 2007 Oct 5.

PMID:
18541260
21.

A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer.

Sasaki H, Okuda K, Takada M, Kawahara M, Kitahara N, Matsumura A, Iuchi K, Kawaguchi T, Kubo A, Endo K, Kawano O, Yukiue H, Yano M, Fujii Y.

J Cancer Res Clin Oncol. 2008 Dec;134(12):1371-6. doi: 10.1007/s00432-008-0411-5. Epub 2008 May 14.

PMID:
18478265
22.

Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer.

Okuda K, Sasaki H, Dumontet C, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y.

Lung Cancer. 2008 Oct;62(1):105-12. doi: 10.1016/j.lungcan.2008.02.021. Epub 2008 Apr 18.

PMID:
18395930
23.

Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma.

Okuda K, Sasaki H, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y.

J Cancer Res Clin Oncol. 2008 Oct;134(10):1105-11. doi: 10.1007/s00432-008-0384-4. Epub 2008 Apr 8.

PMID:
18392851
24.

Expression of AIRE in thymocytes and peripheral lymphocytes.

Suzuki E, Kobayashi Y, Kawano O, Endo K, Haneda H, Yukiue H, Sasaki H, Yano M, Maeda M, Fujii Y.

Autoimmunity. 2008 Mar;41(2):133-9. doi: 10.1080/08916930701773941. Review.

PMID:
18324482
25.

Thymic carcinoma: 30 cases at a single institution.

Yano M, Sasaki H, Yokoyama T, Yukiue H, Kawano O, Suzuki S, Fujii Y.

J Thorac Oncol. 2008 Mar;3(3):265-9. doi: 10.1097/JTO.0b013e3181653c71.

26.

Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer.

Sasaki H, Endo K, Okuda K, Kawano O, Kitahara N, Tanaka H, Matsumura A, Iuchi K, Takada M, Kawahara M, Kawaguchi T, Yukiue H, Yokoyama T, Yano M, Fujii Y.

J Cancer Res Clin Oncol. 2008 May;134(5):569-77. Epub 2007 Oct 12.

PMID:
17932690
27.

CCND1 messenger RNA expression is correlated with EGFR mutation status in lung cancer.

Sasaki H, Okuda K, Endo K, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y.

Clin Lung Cancer. 2007 Sep;8(8):493-6.

PMID:
17922974
28.

EGFR exon 20 insertion mutation in Japanese lung cancer.

Sasaki H, Endo K, Takada M, Kawahara M, Kitahara N, Tanaka H, Okumura M, Matsumura A, Iuchi K, Kawaguchi T, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y.

Lung Cancer. 2007 Dec;58(3):324-8. Epub 2007 Aug 7.

PMID:
17686547
29.

PIK3CA gene amplification in Japanese non-small cell lung cancer.

Kawano O, Sasaki H, Okuda K, Yukiue H, Yokoyama T, Yano M, Fujii Y.

Lung Cancer. 2007 Oct;58(1):159-60. Epub 2007 Aug 6.

PMID:
17681398
30.

ErbB4 expression and mutation in Japanese patients with lung cancer.

Sasaki H, Okuda K, Kawano O, Endo K, Yukiue H, Yokoyama T, Yano M, Fujii Y.

Clin Lung Cancer. 2007 Jul;8(7):429-33.

PMID:
17681096
31.

Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.

Sasaki H, Okuda K, Kawano O, Endo K, Yukiue H, Yokoyama T, Yano M, Fujii Y.

Oncol Rep. 2007 Sep;18(3):623-8.

PMID:
17671710
32.

ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers.

Kawano O, Sasaki H, Endo K, Suzuki E, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

J Surg Res. 2008 May 1;146(1):43-8. Epub 2007 Jul 13.

PMID:
17631905
33.

Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma.

Yano M, Sasaki H, Kobayashi Y, Yukiue H, Haneda H, Suzuki E, Endo K, Kawano O, Hara M, Fujii Y.

J Thorac Oncol. 2006 Jun;1(5):413-6.

34.

Human MOB1 expression in non-small-cell lung cancer.

Sasaki H, Kawano O, Endo K, Suzuki E, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Clin Lung Cancer. 2007 Jan;8(4):273-6.

PMID:
17311693
35.

EGFRvIII mutation in lung cancer correlates with increased EGFR copy number.

Sasaki H, Kawano O, Endo K, Yukiue H, Yano M, Fujii Y.

Oncol Rep. 2007 Feb;17(2):319-23.

PMID:
17203167
36.

Mutation of epidermal growth factor receptor gene in adenosquamous carcinoma of the lung.

Sasaki H, Endo K, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Lung Cancer. 2007 Jan;55(1):129-30. Epub 2006 Dec 6.

PMID:
17156891
37.

PIK3CA mutation status in Japanese lung cancer patients.

Kawano O, Sasaki H, Endo K, Suzuki E, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Lung Cancer. 2006 Nov;54(2):209-15. Epub 2006 Aug 22.

PMID:
16930767
38.

L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.

Sasaki H, Endo K, Takada M, Kawahara M, Kitahara N, Tanaka H, Okumura M, Matsumura A, Iuchi K, Kawaguchi T, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Lung Cancer. 2006 Oct;54(1):103-8. Epub 2006 Aug 4.

PMID:
16890322
39.

Decreased kallikrein 11 messenger RNA expression in lung cancer.

Sasaki H, Kawano O, Endo K, Suzuki E, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Clin Lung Cancer. 2006 Jul;8(1):45-8.

PMID:
16870045
40.

Evaluation of the epidermal growth factor receptor gene mutation and copy number in non-small cell lung cancer with gefitinib therapy.

Endo K, Sasaki H, Yano M, Kobayashi Y, Yukiue H, Haneda H, Suzuki E, Kawano O, Fujii Y.

Oncol Rep. 2006 Sep;16(3):533-41.

PMID:
16865253
41.

Decreased fragile histidine triad gene messenger RNA expression in lung cancer.

Sasaki H, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Clin Lung Cancer. 2006 May;7(6):412-6.

PMID:
16800968
42.

Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.

Suzuki E, Sasaki H, Kawano O, Endo K, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Jpn J Clin Oncol. 2006 Jun;36(6):351-6. Epub 2006 Jun 8.

PMID:
16762968
43.

Preoperative steroid pulse therapy for invasive thymoma: clinical experience and mechanism of action.

Kobayashi Y, Fujii Y, Yano M, Sasaki H, Yukiue H, Haneda H, Suzuki E, Endo K, Kawano O.

Cancer. 2006 May 1;106(9):1901-7.

44.

Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung.

Haneda H, Sasaki H, Shimizu S, Endo K, Suzuki E, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Lung Cancer. 2006 Apr;52(1):47-52. Epub 2006 Feb 28.

PMID:
16503085
45.

A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.

Haneda H, Sasaki H, Lindeman N, Kawano O, Endo K, Suzuki E, Shimizu S, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Jpn J Clin Oncol. 2006 Feb;36(2):69-75. Epub 2006 Jan 31.

PMID:
16449241
46.

Uncommon V599E BRAF mutations in Japanese patients with lung cancer.

Sasaki H, Kawano O, Endo K, Suzuki E, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

J Surg Res. 2006 Jun 15;133(2):203-6. Epub 2005 Dec 27.

PMID:
16376942
47.

Arg and DAP3 expression was correlated with human thymoma stage.

Sasaki H, Ide N, Yukiue H, Kobayashi Y, Fukai I, Yamakawa Y, Fujii Y.

Clin Exp Metastasis. 2004;21(6):507-13.

PMID:
15679048
48.

Decreased Hrad6B expression in lung cancer.

Sasaki H, Moriyama S, Nakashima Y, Yukiue H, Fukai I, Fujii Y.

Acta Oncol. 2004;43(6):585-9.

PMID:
15370617
49.

Elevated serum epidermal growth factor receptor level in stage IV thymoma.

Sasaki H, Yukiue H, Sekimura A, Mizuno K, Konishi A, Yano M, Fukai I, Fujii Y.

Surg Today. 2004;34(5):477-9.

PMID:
15108095
50.

Cten mRNA expression is correlated with tumor progression in thymoma.

Sasaki H, Yukiue H, Kobayashi Y, Fukai I, Fujii Y.

Tumour Biol. 2003 Sep-Oct;24(5):271-4.

PMID:
15001839

Supplemental Content

Loading ...
Support Center